847349-87-5

Basic information

• Product Name: 2-(Benzyloxy)-5-bromo-4-methylpyridine
• Synonyms: 2-(Benzyloxy)-5-bromo-4-methylpyridine;2-(Benzyloxy)-5-bromo-4-picoline
• CAS NO: 847349-87-5
• Molecular Formula: C₁₃H₁₂BrNO
• Molecular Weight: 278.14448
• Mol File: 847349-87-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(Benzyloxy)-5-bromo-4-methylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Benzyloxy)-5-bromo-4-methylpyridine(847349-87-5)
• EPA Substance Registry System: 2-(Benzyloxy)-5-bromo-4-methylpyridine(847349-87-5)

Safety Data

• Hazardous Substances Data: 847349-87-5(Hazardous Substances Data)

Usage

General Description

2-(benzyloxy)-5-bromo-4-methylpyridine is a chemical compound with the molecular formula C14H12BrNO. It is a derivative of pyridine, a heterocyclic aromatic ring compound. The presence of the bromine and methyl groups in the compound gives it unique chemical properties. This chemical is often used in organic synthesis as a reagent or intermediate in the production of various pharmaceuticals and agrochemicals. Its primary use is in the synthesis of complex molecules for medicinal and agricultural purposes. Additionally, it may also have some other potential applications in the field of materials science and other industrial processes.

Upstream product

• 100-51-6 benzyl alcohol 
• 778611-64-6 5-bromo-2-chloro-4-methylpyridine 
• 164513-38-6 5-bromo-4-methylpyridin-2(1H)-one 
• 100-39-0 benzyl bromide 

Downstream Products

• 1189757-59-2 n-propyl 6-(benzyloxy)-4-methylpyridine-3-carboxylate 

Relevant articles and documents

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

The compounds represented by Formula (I) or pharmaceutically acceptable salts thereof: with U, W, X, Y, Z, p and ring A as defined in claim 1. Those compounds are useful for the treatment or prevention of bacteria infections. The variables of Formula (I) are as described herein. Pharmaceutically acceptable compositions comprise the compounds of Formula (I) or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers, adjuvants, or vehicles. Methods of treating bacteria infections employ such compounds or pharmaceutically acceptable salts thereof.

Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor

A series of 2-pyridone-containing imidazoline derivatives was synthesized and evaluated as neuropeptide Y Y5 receptor antagonists. Optimization of the 2-pyridone structure on the 2-position of the imidazoline ring led to identification of 1-(difluoromethy